Aralez Bio
PrivateLast Round
Series A
Oct 29, 2024
Total Funding Raised
$32.6M
Company Overview
Aralez Bio operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Series A round in October 2024.
Aralez Bio is a biotechnology company that develops and manufactures noncanonical amino acids using a proprietary enzymatic platform for pharmaceutical, agricultural, and cosmetic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aralez Bio Comparables
Compare Aralez Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iris Biotech GmbH | 76% | |
| Allozymes | 74% | |
| Codexis | 71% |
For institutional investors. Book with your work email.
Aralez Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 29, 2024 | ||||
| Grant | Oct 3, 2024 | ||||
| Seed | Aug 22, 2022 | ||||
| Accelerator | May 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aralez Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Impact Science | Series A |
| Spero Ventures | Series A |
| Good Growth Capital | Seed, Series A |
| U.S. Department of Health and Human Services | Grant |
| Rothenberg Innovation Initiative | Accelerator |
| Cyclotron Road | Accelerator |
| Climate Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 43% MoM, from 2.4K to 3.4K.
- Jun 1, 2025
Grew 36% QoQ, from 25 to 34 employees.
For institutional investors. Book with your work email.
Aralez Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aralez Bio's valuation, stock price, and market status.
Is Aralez Bio a public or private company?
Aralez Bio is a private company.
What is the current stock price of Aralez Bio?
Aralez Bio is a private company, so its shares have no public market price. Caplight tracks Aralez Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aralez Bio worth (valuation)?
Valuation information for Aralez Bio is not publicly available.
Can I buy Aralez Bio stock?
Aralez Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aralez Bio's last funding round?
Aralez Bio's most recent funding round was Series A on October 29, 2024.
Who are the main investors in Aralez Bio?
Key investors in Aralez Bio include Spero Ventures, Paladin Capital Group.
Will Aralez Bio IPO soon?
No public IPO plans have been announced for Aralez Bio.
How can I track Aralez Bio secondary market activity?
Caplight tracks bids, offers, and trades in Aralez Bio's shares on secondary markets.